About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 613475, 9 pages
http://dx.doi.org/10.1155/2013/613475
Research Article

Effects of Age and Sex on Estimated Diabetes Prevalence Using Different Diagnostic Criteria: The Tromsø OGTT Study

1Tromsø Endocrine Research Group, Department of Clinical Medicine, University of Tromsø, 9037 Tromsø, Norway
2Division of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway
3Department of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
4Department of Medical Biology, University of Tromsø, 9037 Tromsø, Norway
5Division of Laboratory Medicine, University Hospital of North Norway, 9038 Tromsø, Norway

Received 27 September 2012; Revised 4 December 2012; Accepted 5 December 2012

Academic Editor: Mario Maggi

Copyright © 2013 Moira Strand Hutchinson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation, World Health Organization, Geneva, Switzerland, 2011.
  2. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, supplement 1, pp. S64–S71, 2012.
  3. D. B. Sacks, “A1C versus glucose testing: a comparison,” Diabetes Care, vol. 34, no. 2, pp. 518–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Scopus
  5. S. Colagiuri, C. M. Y. Lee, T. Y. Wong, B. Balkau, J. E. Shaw, and K. Borch-Johnsen, “Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes,” Diabetes Care, vol. 34, no. 1, pp. 145–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Rathmann, B. Kowall, T. Tamayo, et al., “Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study,” Annals of Internal Medicine, vol. 44, no. 2, pp. 170–177, 2012.
  7. C. C. Cowie, K. F. Rust, D. D. Byrd-Holt et al., “Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006,” Diabetes Care, vol. 33, no. 3, pp. 562–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Borg, D. Vistisen, D. R. Witte, and K. Borch-Johnsen, “Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study,” Diabetic Medicine, vol. 27, no. 8, pp. 906–910, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Mostafa, M. J. Davies, D. Webb et al., “The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus,” Diabetic Medicine, vol. 27, no. 7, pp. 762–769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Cosson, M. T. Nguyen, E. Hamo-Tchatchouang et al., “What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998–2006?” Diabetic Medicine, vol. 28, no. 5, pp. 567–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Lorenzo and S. M. Haffner, “Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study,” Diabetes Care, vol. 33, no. 2, pp. 335–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. Christensen, D. R. Witte, L. Kaduka et al., “Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups,” Diabetes Care, vol. 33, no. 3, pp. 580–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. T. Saltevo, H. Kautiainen, L. Niskanen, et al., “Ageing and associations of fasting plasma glucose and 2h plasma glucose with HbA(1C) in apparently healthy population., “FIN-D2D” study,” Diabetes Research and Clinical Practice Journal, vol. 93, pp. 344–349, 2011.
  14. M. S. Hutchinson, R. M. Joakimsen, I. Njolstad, H. Schirmer, Y. Figenschau, and R. Jorde, “Haemoglobin A1c in diagnosis of diabetes mellitus and pre-diabetes, validation by oral glucose tolerance test. The Tromso OGTT Study,” Journal of Endocrinological Investigation, vol. 35, no. 9, pp. 835–840, 2012.
  15. R. R. Little, C. L. Rohlfing, and D. B. Sacks, “Status of hemoglobin A1c measurement and goals for improvement: from Chaos to order for improving diabetes care,” Clinical Chemistry, vol. 57, no. 2, pp. 205–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Katz, S. S. Nambi, K. Mather et al., “Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 7, pp. 2402–2410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Scopus
  18. M. Gutt, C. L. Davis, S. B. Spitzer et al., “Validation of the insulin sensitivity index (ISI0,120): comparison with other measures,” Diabetes Research and Clinical Practice, vol. 47, no. 3, pp. 177–184, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. “International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, pp. 1327–1334, 2009.
  20. “Consequences of the new diagnostic criteria for diabetes in older men and women: The DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe),” Diabetes Care, vol. 22, no. 10, pp. 1667–1671, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. B. Davidson, “The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly,” Metabolism: Clinical and Experimental, vol. 28, no. 6, pp. 688–705, 1979. View at Scopus
  22. P. Iozzo, H. Beck-Nielsen, M. Laakso, U. Smith, H. Yki-Järvinen, and E. Ferrannini, “Independent influence of age on basal insulin secretion in nondiabetic humans,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 3, pp. 863–868, 1999. View at Scopus
  23. P. Imbeault, J. B. Prins, M. Stolic et al., “Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence,” Diabetes Care, vol. 26, no. 2, pp. 480–484, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Færch, K. Borch-Johnsen, A. Vaag, T. Jørgensen, and D. R. Witte, “Sex differences in glucose levels: a consequence of physiology or methodological convenience? the Inter99 study,” Diabetologia, vol. 53, no. 5, pp. 858–865, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Sicree, P. Z. Zimmet, D. W. Dunstan, A. J. Cameron, T. A. Welborn, and J. E. Shaw, “Differences in height explain gender differences in the response to the oral glucose tolerance test—The AusDiab study,” Diabetic Medicine, vol. 25, no. 3, pp. 296–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Boronat, P. Saavedra, L. Lopez-Rios, M. Riano, A. M. Wagner, and F. J. Nóvoa, “Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test,” Diabetes Care, vol. 33, no. 12, pp. 2671–2673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Borg, J. C. Kuenen, B. Carstensen et al., “HbA1cand mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: The A1C-Derived Average Glucose (ADAG) study,” Diabetologia, vol. 54, no. 1, pp. 69–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. K. T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day, “Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk,” Annals of Internal Medicine, vol. 141, no. 6, pp. 413–420, 2004. View at Scopus
  29. J. B. Meigs, D. M. Nathan, R. B. D'Agostino, and P. W. F. Wilson, “Fasting and postchallenge glycemia and cardiovascular disease risk: the framingham offspring study,” Diabetes Care, vol. 25, no. 10, pp. 1845–1850, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. The DECODE Study Group, “Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria,” Archives of Internal Medicine, vol. 161, pp. 397–405, 2001.
  31. A. C. Dale, K. Midthjell, T. I. Nilsen, R. Wiseth, and L. J. Vatten, “Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway,” European Heart Journal, vol. 30, no. 11, pp. 1372–1377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Selvin, C. M. Crainiceanu, F. L. Brancati, and J. Coresh, “Short-term variability in measures of glycemia and implications for the classification of diabetes,” Archives of Internal Medicine, vol. 167, no. 14, pp. 1545–1551, 2007. View at Publisher · View at Google Scholar · View at Scopus